SFNC Q1 2026 Earnings EPS Misses Estimates as Shares Slip Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss FirstCash Holdings FCFS Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher AMTM Q1 2026 Earnings EPS Beats Estimates by 26 Revenue Details Not Reported YETI Q1 2026 Earnings Strong EPS Beat Drives Stock Higher NAT Q4 2025 Earnings Significant EPS Miss Sends Stock Lower